Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2005
08/04/2005CA2553257A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
08/04/2005CA2553221A1 Folate conjugates and complexes
08/04/2005CA2553199A1 System for up-regulating bone morphogenetic protein (bmp) gene expression in bone cells via the application of fields generated by specific electric and electromagnetic signals
08/04/2005CA2552894A1 Methods of using high affinity atiii variants
08/04/2005CA2552892A1 O-linked glycosylation of peptides
08/04/2005CA2552882A1 Methods for diagnosis and prognosis of cancers of epithelial origin
08/04/2005CA2552756A1 Mouse model for psoriasis and psoriatic arthritis
08/04/2005CA2552043A1 Transglutaminase mediated conjugation of peptides
08/04/2005CA2550551A1 Fusion polypeptides capable of activating receptors
08/04/2005CA2544762A1 Site-specific coupling of polypeptides
08/03/2005EP1560026A1 Methods of detecting collagen degradation
08/03/2005EP1560025A2 Specific markers for diabetes
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559790A1 Vesicles for the removal of substances from liquids
08/03/2005EP1559786A1 Membrane protein originating in mast cells
08/03/2005EP1559780A1 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559725A1 Antigen recognizing antibody
08/03/2005EP1559724A1 Glp-1 derivatives and transmicosal absorption preparations thereof
08/03/2005EP1559723A1 A segment of glycosylation-deficient HGF alpha-chain
08/03/2005EP1559722A1 Caenorhabditis elegans p21-activated kinase (PAK) gene and associated loss-of-function phenotypes
08/03/2005EP1559721A1 Novel fprl1 ligands and use thereof
08/03/2005EP1559712A1 A method for manufacturing optically active coumaryl amino acid salts and the coumaryl aminoacid salts thus obtained
08/03/2005EP1558766A2 Use of a33 antigens and jam-it
08/03/2005EP1558760A2 Crh responsive genes in cns
08/03/2005EP1558747A2 Glycoprotein synthesis
08/03/2005EP1558746A2 Nucleic acids encoding duramycin
08/03/2005EP1558742A2 Methods of modulating cytokinin related processes in a plant using b3 domain proteins
08/03/2005EP1558740A2 Recombinant protein variants
08/03/2005EP1558737A1 Gene families associated with cancers
08/03/2005EP1558728A2 Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
08/03/2005EP1558726A1 Vaccines against west nile virus
08/03/2005EP1558644A2 A structured peptide scaffold for displaying turn libraries on phage
08/03/2005EP1558643A2 T cell receptor display
08/03/2005EP1558642A1 Chimeric cytoplasmic signalling molecules
08/03/2005EP1558641A1 Crystals of insulin analogues and method for the production thereof
08/03/2005EP1558640A2 Trimeric binding proteins for trimeric cytokines
08/03/2005EP1558639A2 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
08/03/2005EP1558638A2 P53 binding polypeptide
08/03/2005EP1558636A2 Vaccine
08/03/2005EP1558635A2 Vaccine
08/03/2005EP1558633A1 COMPOSITION FOR THE TREATMENT OF INFECTION BY i FLAVIVIRIDAE /i VIRUSES
08/03/2005EP1558631A2 Methods and compositions for diagnosing and treating companion animal cancer
08/03/2005EP1558629A2 Synthetic chemokines labeled at selected positions
08/03/2005EP1558628A1 Antigenic peptides
08/03/2005EP1558444A2 Silk biomaterials and methods of use thereof
08/03/2005EP1558354A2 Using amines or amino acids as mobile phase modifiers in chromatography
08/03/2005EP1558287A2 Uses of human zven antagonists
08/03/2005EP1558286A2 Assay for autoantibodies to folate receptors
08/03/2005EP1558285A1 Method for decreasing depression by inhibiting the activity of n-type calcium channel
08/03/2005EP1558283A2 Hcv vaccine compositions comprising e1 and ns3 peptides
08/03/2005EP1558280A2 Compositions and methods for treating or preventing pneumococcal infection
08/03/2005EP1558278A2 Production of homotrimeric fusion proteins
08/03/2005EP1558276A2 Flaviviris fusion inhibitors
08/03/2005EP1558275A2 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation
08/03/2005EP1558274A2 Methods for controlling proliferation of cells
08/03/2005EP1558273A2 Treatment and prevention of pulmonary conditions
08/03/2005EP1558233A2 Treating androgen decline in aging male (adam)-associated conditions with sarms
08/03/2005EP1368050A4 Virus derived antimicrobial peptides
08/03/2005EP1330517A4 Identification and characterization of an anthocyanin mutant (ant1) in tomato
08/03/2005EP1280895B1 Polypeptide inhibiting a proton-gated na+ channel
08/03/2005EP1267899B1 Ssa inactivated salmonella vaccines
08/03/2005EP1196439B1 Compounds exhibiting an antibiotic activity
08/03/2005EP1169483B1 Variation in drug response related to polymorphisms in beta2- adrenergic receptor
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
08/03/2005EP1049777B1 Acpl dna and polypeptides
08/03/2005EP1012285B1 Beta-defensins
08/03/2005EP1012265B1 Repressed trans-activator system for characterization of protein-protein interactions
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0896620B1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein
08/03/2005EP0851925B1 Human growth hormone variants
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005EP0707596B1 Polymer-peptide conjugates
08/03/2005EP0702722B1 Plasmids suitable for gene therapy
08/03/2005CN1650018A Insect resistant plants and methods for making same
08/03/2005CN1650015A DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
08/03/2005CN1650014A Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
08/03/2005CN1650013A DNA vaccines against hantavirus infections
08/03/2005CN1650012A Antigens encoded by alternative reading frame from pathogenic viruses
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1650008A Alga-origin promoter, intron and terminator
08/03/2005CN1650005A Antimicrobial polypeptide and utizliation thereof
08/03/2005CN1649901A Specific antibody fragments for the human carcinoembryonic antigen (cea)
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649899A Connective tissue stimulating peptides
08/03/2005CN1649898A Novel peptides and the application thereof in therapy
08/03/2005CN1649897A FALP proteins
08/03/2005CN1649896A Height-related gene
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649894A A method for identification, isolation and production of antigens to a specific pathogen
08/03/2005CN1649890A Anti-protozoal vaccine
08/03/2005CN1649626A Use of molecules which interact with the haptoglobin receptor ligand binding
08/03/2005CN1649623A Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
08/03/2005CN1649496A Composition and method to alter lean body mass and bone properties in a subject
08/03/2005CN1649483A ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants
08/03/2005CN1648665A Recombined pronucleus expression detection antigen for detecting goose parvovirus anti-body and preparing method
08/03/2005CN1648254A Goose parvo-virus VP1 and VP3 gene non-overlapping sequence pronucleus expression protein and its preparing method
08/03/2005CN1648247A Method for producing recombined blood vessel chalone in bacillus coli and its use